Atlas Trials

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

Clinical trial NCT05097287 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05097287
Sponsor
Sanofi
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Asthma
Start date
2021-12-16
Primary completion
2027-03-16
Enrollment
1339

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.